It may be possible to predict diagnostic transition to schizophrenia and bipolar disorder from machine learning models.

Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...

Affinity Technologies today announced strategic actions to cut $4 million in annual costs at its subsidiary CAP/CLIA ...

Genomenon, a leader in genomic intelligence, today announced the launch of an enhanced AI-powered integration for its Mastermind Genomic Intelligence Platform. This new capability further refines ...

According to WHO, cognitive health, in particular, is the ability to think, learn, and remember and is crucial for ...

Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the launch of the aPAP ClearPath Dried Blood Spot (DBS) Test in the U.S., an ...

On June 15, 2020, Plaintiff Gelt Trading, Ltd. filed a securities class action against Co-Diagnostics, Inc. and certain of the Company's current and former directors and officers alleging violations ...

Individuals with generalized anxiety disorder (GAD), a condition characterized by daily excessive worry lasting at least six ...

A machine learning model using existing clinical data may help clinicians screen for comorbid anxiety and depression in ...

DelveInsight's Biosensors Market Insights report provides the current and forecast market analysis, individual leading ...

CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...